Clinical trials: Subjects Presenting With Normal Eyes
Subjects Presenting With Normal or With Ocular Pathology
Clinical Validation of New OCT System
To demonstrate clinical substantial equivalence of DRI OCT-1 as comparable to the commercially available Cirrus
- Trial name
- NCT01809704
- Where
- 3 sites in United States
- Volunteers
- 87 people, healthy volunteers welcome
- Sponsor
- Topcon Medical Systems, Inc.
Subjects Presenting With Normal Eyes
TopQ Cut-off Score Validation Study for 3D OCT-1 Maestro
The objective of this study is to validate the TopQ cutoff scores, which have been previously determined.
- Trial name
- NCT02447133
- Testing
- 3D OCT-1 Maestro
- Where
- United States
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Topcon Medical Systems, Inc.